Skip to content

How one statistician is refining clinical trials

Biomed Bites is back. It's a weekly feature that introduces readers to some of Stanford's most innovative biomedical researchers. 

A love of mathematics propelled Ying Lu, PhD, to his current position as professor of health research and policy - with a specialty in biostatistics.

As the genomic revolution generates skyscrapers of data, biostatisticians like Lu are scrambling to develop more effective and efficient ways to design experiments and conduct clinical trials. Here's Lu in the video above:

My research focuses on the development and application of novel, cutting-edge biostatistical methods in the evaluation, validation and comparison of new medical diagnoses as well as treatment interventions.

Lu also directs the nearby VA Cooperative Studies Program Coordinating Center, which conducts national clinical trials on topics such as stroke prevention, post-traumatic stress disorder and heart failure treatment.

Learn more about Stanford Medicine’s Biomedical Innovation Initiative and about other faculty leaders who are driving biomedical innovation here.

Previously: What I did this summer: Stanford medical student investigates health statistics and costs in Costa Rica, It all comes down to truth: Stanford med student digs in on public-health campaigns and How the FDA is promoting data sharing and transparency to support innovations in public health

Popular posts

Sex biology redefined: Genes don’t indicate binary sexes

The scenario many of us learned in school is that two X chromosomes make someone female, and an X and a Y chromosome make someone male. These are simplistic ways of thinking about what is scientifically very complex.